Elephant Vert (EV) and CABI share their expertise in an FAO discussion paper exploring the use of microbial and invertebrate biological control agents.
Contribution of Green Elephant (EV) – The global biostimulants market size will reach USD 9.25 billion in 2030.
Elephant Vert (EV) participates in a technical workshop on locusts in Central Asia and the Caucasus 2022.
Rignac, Close-up on a Bio3G pilot farm, French subsidiary of the Elephant Vert (EV) group in Aveyron.
Lipofabrik, R&D laboratory of the Elephant Vert (EV) group: Bio-inspired rhamnolipids, cyclic lipopeptides and a chito-oligosaccharide provide protection against wheat powdery mildew and inhibit the germination of conidia.
Lipofabrik, R&D laboratory of the Éléphant Vert (EV) group: Evaluation of mixtures of lipopeptides produced by Bacillus subtilis as biological control products against apple scab (Venturia inaequalis).
Through its new strategy, Eléphant Vert (EV) marks its territory in the world of agricultural biosolutions.
